Danaher (NYSE:DHR) Issues FY 2026 Earnings Guidance

Danaher (NYSE:DHR) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 8.350-8.550 for the period, compared to the consensus EPS estimate of 8.400. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several research firms have commented on DHR. The Goldman Sachs Group lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Jefferies Financial Group decreased their target price on Danaher from $265.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. Argus set a $265.00 target price on Danaher in a report on Wednesday, January 14th. Finally, KeyCorp reiterated an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Eighteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $246.50.

Danaher Stock Up 0.5%

Shares of NYSE DHR opened at $195.79 on Tuesday. The company has a market cap of $138.56 billion, a P/E ratio of 38.85, a P/E/G ratio of 2.64 and a beta of 0.95. Danaher has a 12-month low of $180.03 and a 12-month high of $242.80. The stock has a fifty day moving average price of $198.39 and a 200 day moving average price of $214.70. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%. Research analysts anticipate that Danaher will post 8.4 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.40 dividend. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is currently 31.75%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Danaher

Institutional investors and hedge funds have recently bought and sold shares of the stock. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter worth $26,000. Transamerica Financial Advisors LLC increased its stake in shares of Danaher by 216.3% in the fourth quarter. Transamerica Financial Advisors LLC now owns 155 shares of the conglomerate’s stock worth $36,000 after buying an additional 106 shares during the last quarter. Birchwood Financial Partners Inc. bought a new stake in shares of Danaher in the fourth quarter worth $41,000. Finally, Quattro Advisors LLC bought a new stake in shares of Danaher in the fourth quarter worth $52,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.